2015 Joint Annual Meeting
Search Meeting Site Only
NEAUA Main Site
Annual Meeting Home
Program
Accreditation
Past & Future Meetings

Back to 2015 Joint Annual Meeting


Fournier's Gangrene: A Modern Analysis of Predictors of Outcomes
Jeffrey D Sparenborg1, Yeonjoo Choi1, Krishnan Venkatesan2, Mohan Verghese2, Jonathan Hwang2
1Medstar Georgetown University, Washington, DC;2Medstar Washington Hospital Center, Washington, DC

Introduction:
This study identifies the predisposing factors related to Fournier’s
gangrene and validate the Fournier’s gangrene severity Index score as a prognostictool in the care of the Fournier’s patient.
Materials & Methods:
Medstar Washington Hospital Center records
were searched from January 2003 to February 2015 for all patients with a diagnosis code of Fournier’s gangrene, n = 40.
Epidemiologic Data was collected for patients e.g., age, PMH, labs, etc, and used to calculate an FGSI score.
Results: The average age was 53.45yrs and M/F ratio was 39:1.
Patients presented with an average 2.675 predisposing factors; the most common was diabetes mellitus (n=21) followed by hypertenstion (n=18). The most common etiology was periscrotal (n=25) next to perirectal (n=9). Streptcotoccus was the most common source of infection (n=14). Patients on average required three surgical interventions. The average and median hospitalization period was 19.625 and 11.5 days respectively. 11 patients developed sepsis. 24 (60%) patients experienced a complication. The overall mortality was 5% (n=2). The average FGSI on admission was 5.368. Multivariate analysis showed FGSI score correlates with more surgical intervention, longer hospitalization, sepsis, complication and mortality.
Conclusions:
The FGSI score predicts a greater likelihood of more surgical interventions, longer hospitalization period, sepsis,
complications and mortality within this patient population. Diabetes mellitus continues to be the most common predisposing factors in FG patients. The mortality rate of 5% is much less than the historically reported 20-30% and may reflect improved understanding and care of this aggressive disease.


Back to 2015 Joint Annual Meeting